AKT1 and non-small cell lung carcinoma: In human non-small cell lung cancer (NSCLC), miR-1179 inhibited the growth and invasion of NSCLC cells by targeting SPAG5 and inhibiting Akt, highlighting the importance of the miR-1179/SPAG5/Akt axis in the progression of NSCLC [25].